A Model to Identify Specific Predictors of Spatial Neglect Recovery
Comparing Prism Adaptation Therapy and Bromocriptine Medication for Spatial Neglect: Theoretical and Practical Outcomes
2 other identifiers
observational
80
1 country
3
Brief Summary
This study examines methods to better predict improvement of a hidden disability of functional vision, spatial neglect, following stroke. Spatial neglect is a tendency to make visual judgment and movement errors mislocating the body and objects in space. The investigators are using specialized statistical methods to compute the proportion of improvement accounted for by personal characteristics of each stroke survivor, the proportion of improvement accounted for by the unique visual-spatial errors made by each subject, and the proportion of improvement accounted for by each treatment administered. The investigators will also examine whether brain imaging predicts how rapidly improvement occurs. Lastly, the study tests whether improvements that are meaningful to the survivor can be measured in a way that still allows detection of small and scientifically eloquent performance changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2009
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 27, 2009
CompletedFirst Posted
Study publicly available on registry
October 6, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedFebruary 17, 2021
February 1, 2021
12.8 years
July 27, 2009
February 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparing two treatments for hidden disabilities in functional vision after stroke.
6 months
Study Arms (2)
Prism adaptation therapy
Patients receive prism adaptation therapy by protocol (Frassinetti et al., 2002)
Bromocriptine pharmacotherapy
Patients receive bromocriptine pharmacotherapy by protocol (Barrett et al., 1999)
Eligibility Criteria
Stroke survivors with right brain stroke and evidence of a hidden disability of functional vision (spatial neglect)
You may qualify if:
- Stroke survivors with right brain stroke and evidence of a hidden disability of functional vision (spatial neglect)
- Can give consent
You may not qualify if:
- Other neurological conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Kessler Institute of Rehabilitation
Chester, New Jersey, 07930, United States
Kessler Institute of Rehabilitation
Saddle Brook, New Jersey, 07663, United States
Kessler Foundation Research Center
West Orange, New Jersey, 07052, United States
Related Publications (1)
Boukrina O, Chen P, Budinoska T, Barrett AM. Exploratory examination of lexical and neuroanatomic correlates of neglect dyslexia. Neuropsychology. 2020 May;34(4):404-419. doi: 10.1037/neu0000619. Epub 2020 Jan 30.
PMID: 31999167DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
A M Barrett, MD
Kessler Foundation
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Stroke Research
Study Record Dates
First Submitted
July 27, 2009
First Posted
October 6, 2009
Study Start
January 1, 2009
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
February 17, 2021
Record last verified: 2021-02